Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

K Webster

Showing results (471-480 of 492) with videos related to

Pageof 50
Sort By:
The British Journal of Surgery|February 15, 2000
Lymphocyte activation after non-thermal traumaD S Walsh, P Siritongtaworn, K Pattanapanyasat, et al.
Annals of Internal Medicine|October 16, 2002
Ximelagatran versus warfarin for the prevention of venous thromboembolism after total knee arthroplasty. A randomized, double-blind trialCharles W Francis, Bruce L Davidson, Scott D Berkowitz, et al.
G3 (Bethesda, Md.)|August 25, 2019
Population Selection and Sequencing of <i>Caenorhabditis elegans</i> Wild Isolates Identifies a Region on Chromosome III Affecting Starvation ResistanceAmy K Webster, Anthony Hung, Brad T Moore, et al.
American Journal of Human Genetics|October 31, 2000
Distinct missense mutations of the FGFR3 lys650 codon modulate receptor kinase activation and the severity of the skeletal dysplasia phenotypeG A Bellus, E B Spector, P W Speiser, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 1, 1997
Phase I trial of docetaxel and cisplatin in previously untreated patients with advanced non-small-cell lung cancerM J Millward, J Zalcberg, J F Bishop, et al.
The AAPS Journal|August 24, 2017
Approaches for Establishing Clinically Relevant Dissolution Specifications for Immediate Release Solid Oral Dosage FormsAndre Hermans, Andreas M Abend, Filippos Kesisoglou, et al.
Journal of Pharmaceutical Sciences|October 28, 2017
Industry's View on Using Quality Control, Biorelevant, and Clinically Relevant Dissolution Tests for Pharmaceutical Development, Registration, and CommercializationHaiyan Grady, David Elder, Gregory K Webster, et al.
Journal of Clinical Epidemiology|March 4, 2021
Measuring the success of blinding in placebo-controlled trials: Should we be so quick to dismiss it?Rebecca K Webster, Felicity Bishop, Gary S Collins, et al.
Biochemical Pharmacology|March 9, 2006
Preclinical analysis of the analinoquinazoline AG1478, a specific small molecule inhibitor of EGF receptor tyrosine kinaseA G Ellis, M M Doherty, F Walker, et al.
Journal of Plastic, Reconstructive & Aesthetic Surgery : JPRAS|November 7, 2025
Enhancing patient satisfaction in postoperative drain management: A comparison of traditional and digital recording methodsMyles N LaValley, Hannah L Scales, Theresa K Webster, et al.
Pageof 50

Showing results (471-480 of 492) with videos related to

Sort By:
Pageof 50
The British Journal of Surgery|February 15, 2000
Lymphocyte activation after non-thermal traumaD S Walsh, P Siritongtaworn, K Pattanapanyasat, et al.
Annals of Internal Medicine|October 16, 2002
Ximelagatran versus warfarin for the prevention of venous thromboembolism after total knee arthroplasty. A randomized, double-blind trialCharles W Francis, Bruce L Davidson, Scott D Berkowitz, et al.
G3 (Bethesda, Md.)|August 25, 2019
Population Selection and Sequencing of <i>Caenorhabditis elegans</i> Wild Isolates Identifies a Region on Chromosome III Affecting Starvation ResistanceAmy K Webster, Anthony Hung, Brad T Moore, et al.
American Journal of Human Genetics|October 31, 2000
Distinct missense mutations of the FGFR3 lys650 codon modulate receptor kinase activation and the severity of the skeletal dysplasia phenotypeG A Bellus, E B Spector, P W Speiser, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 1, 1997
Phase I trial of docetaxel and cisplatin in previously untreated patients with advanced non-small-cell lung cancerM J Millward, J Zalcberg, J F Bishop, et al.
The AAPS Journal|August 24, 2017
Approaches for Establishing Clinically Relevant Dissolution Specifications for Immediate Release Solid Oral Dosage FormsAndre Hermans, Andreas M Abend, Filippos Kesisoglou, et al.
Journal of Pharmaceutical Sciences|October 28, 2017
Industry's View on Using Quality Control, Biorelevant, and Clinically Relevant Dissolution Tests for Pharmaceutical Development, Registration, and CommercializationHaiyan Grady, David Elder, Gregory K Webster, et al.
Journal of Clinical Epidemiology|March 4, 2021
Measuring the success of blinding in placebo-controlled trials: Should we be so quick to dismiss it?Rebecca K Webster, Felicity Bishop, Gary S Collins, et al.
Biochemical Pharmacology|March 9, 2006
Preclinical analysis of the analinoquinazoline AG1478, a specific small molecule inhibitor of EGF receptor tyrosine kinaseA G Ellis, M M Doherty, F Walker, et al.
Journal of Plastic, Reconstructive & Aesthetic Surgery : JPRAS|November 7, 2025
Enhancing patient satisfaction in postoperative drain management: A comparison of traditional and digital recording methodsMyles N LaValley, Hannah L Scales, Theresa K Webster, et al.
Pageof 50